Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: villani v. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.
Minniti G, Scaringi C, Arcella A, Lanzetta G, Di Stefano D, Scarpino S, Bozzao A, Pace A, Villani V, Salvati M, Esposito V, Giangaspero F, Enrici RM. Minniti G, et al. Among authors: villani v. J Neurooncol. 2014 Jun;118(2):377-383. doi: 10.1007/s11060-014-1443-0. Epub 2014 Apr 20. J Neurooncol. 2014. PMID: 24748470
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.
Vaccaro V, Fabi A, Vidiri A, Giannarelli D, Metro G, Telera S, Vari S, Piludu F, Carosi MA, Villani V, Cognetti F, Pompili A, Marucci L, Carapella CM, Pace A. Vaccaro V, et al. Among authors: villani v. Biomed Res Int. 2014;2014:351252. doi: 10.1155/2014/351252. Epub 2014 May 4. Biomed Res Int. 2014. PMID: 24877084 Free PMC article. Clinical Trial.
Home care for brain tumor patients.
Pace A, Villani V, Di Pasquale A, Benincasa D, Guariglia L, Ieraci S, Focarelli S, Carapella CM, Pompili A. Pace A, et al. Among authors: villani v. Neurooncol Pract. 2014 Mar;1(1):8-12. doi: 10.1093/nop/npt003. Neurooncol Pract. 2014. PMID: 26034609 Free PMC article.
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F, Vidiri A, Schillaci O, Floris R, Marzi S, Fabi A, Pace A. Villani V, et al. Anticancer Res. 2015 Sep;35(9):5117-22. Anticancer Res. 2015. PMID: 26254416
209 results